Leadership

Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.

Amid rapid shifts in technology and consumer engagement, Pharm Exec explores how new models in hiring and recruitment-along with the evolution of the C-suite-are reshaping biopharma’s talent path of the future.

Senior leaders in the life sciences share stories on making the jump from the pharma to biotech worlds-and the innate drivers behind such moves.

Practitioners in the field of HEOR training and education outline how the best courses are responding to advancing industry needs.

Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry-and establish new pathways for traditional executive roles in the life sciences.

This article shares practical advice, best practices, and real-world examples of how to hire talent for a successful commercial launch.

The role of the medical affairs professional in the biopharma hierarchy has grown considerably in recent years, but challenges remain in its accent to true strategic partner with the C-suite.

Without considering the organizational and talent aspects of change, companies put themselves at risk for poor employee engagement, loss of talent, and ultimately, failed business initiatives, writes Viq Prevaaz.

To attract the best talent, offer a workplace that inspires.

How one pharma vet helped create the first industry-wide training standards for aspiring medical affairs professionals. 

As we again highlight a roster of emerging leaders in pharma, I wanted to recognize Pharm Exec's own unique team behind the scenes.

An honoree at HBA’s recent Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.

There's no shortage of talent, expertise and passion in the biopharma industry. It's time for that talent to shine.

Pharma and biotech needs cultivate fast-performing leadership in our companies, writes Bagrat Lalayan. Here, he outlines a model to get the best results in a competitive business environment.

Two topics in Pharm Exec this month-rare disease research and women in healthcare leadership-share a "common" thread.

Geoff Newman looks at how pharma and biotech interim management has evolved in the last 20 years.

Pharm Exec explores the power of workplace aesthetic on the intangibles of culture, morale-and corporate mission-in a visit to one big Pharma's unique US headquarters.

Why the industry needs more women in senior management roles-and the three strategies to get there.

The key to success in the modern pharma era is engaging a workforce that's flexible enough to keep pace with evolving needs. That’s where contingent labor comes in, writes Rebecca Cenni.

Amid the release of our eighth list of Emerging Pharma Leaders, it's fitting to take a look at the trends and values that will determine true leadership in big Pharma in the years ahead.

Institutionalizing the teachable moment with GENiE, and new network focused on advancing the idea that for healthcare to change, the education of its leaders must change first.

William Looney speaks to Dr. Claudia Graeve, who leads the Healthcare Businesswomen's Association's sole international chapter in Europe, on improving the prospects for female managers in the region.

How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality, by Lundbeck's Timothy White.

The Jim Carrey film Liar Liar showed us the comic consequences of always telling the truth. What if people in business did the same? Mike Straw considers what the impact on pharma would be.

Rick Koonce outlines the critical coaching steps to help top managers realize their potential in an industry undergoing significant restructuring of both human and financial capital.

John Ansell assesses the wide range of pharma MBA courses currently available, from the five-day "mini MBA" to year-long programs of study.

Lessons to win in a shifting market dynamic

Establishing a well-defined training program is a crucial activity for any biopharmaceutical organization, writes Susan J. Schniepp.

Commercial teams as well as patients can benefit from managed access programs.